BWPP Biological Weapons Reader

Total Page:16

File Type:pdf, Size:1020Kb

BWPP Biological Weapons Reader BWPP Biological Weapons Reader Edited by Kathryn McLaughlin and Kathryn Nixdorff Geneva 2009 About BWPP The BioWeapons Prevention Project (BWPP) is a global civil society activity that aims to strengthen the norm against using disease as a weapon. It was initiated by a group of non- governmental organizations concerned at the failure of governments to act. The BWPP tracks governmental and other behaviour that is pertinent to compliance with international treaties and other agreements, especially those that outlaw hostile use of biotechnology. The project works to reduce the threat of bioweapons by monitoring and reporting throughout the world. BWPP supports and is supported by a global network of partners. For more information see: http://www.bwpp.org Table of Contents Preface .................................................................................................................................................ii Abbreviations .....................................................................................................................................iii Chapter 1. An Introduction to Biological Weapons ......................................................................1 Malcolm R. Dando and Kathryn Nixdorff Chapter 2. History of BTW Disarmament...................................................................................13 Marie Isabelle Chevrier Chapter 3. The Biological Weapons Convention: Content, Review Process and Efforts to Strengthen the Convention.........................................................................................19 Piers D. Millett Chapter 4. Developments in Science and Technology: Relevance for the BWC........................33 Kathryn Nixdorff and Malcolm R. Dando Chapter 5. A Brief Comparison of the Biological and Chemical Weapons Conventions...........45 Scott Spence and Ralf Trapp Chapter 6. Biological Weapons as a Public Health Issue............................................................53 Nicolas Isla Chapter 7. Biological Weapons as an Environmental Issue........................................................59 Kathryn McLaughlin Chapter 8. Biological Weapons as a Biodiversity Issue..............................................................67 Kathryn McLaughlin Chapter 9. Awareness-raising, Education and Codes of Conduct within the Framework of the BWC ..........................................................................................................................83 Robert J. Mathews and John M. Webb Factsheet: Bioterrorism ...............................................................................................................95 Iris Hunger Factsheet: BWC Implementation ................................................................................................97 Angela Woodward, Scott Spence and Rocio Escauriaza Leal Glossary ............................................................................................................................................99 Contributors ....................................................................................................................................115 - i - Preface It has been predicted that the 21st century will see a biological epoch to rival revolutions in information technology, industrial chemistry, and manufacturing processes. Such developments, heralded as offering unparalleled benefits for humanity, have all ultimately been used for hostile purposes. We know that some have already used biology for malign ends (Chapter 1) and that such efforts have not been the preserve of states alone (Factsheet 1). We must work diligently to ensure that this ‘Century of Biology’ does not result in a new biological arms race. There is a rich history of efforts to ensure biology is used only for peaceful purposes (Chapter 2). The most recent chapter of this saga focuses on the treaty to ban the acquisition of biological weapons – the Biological and Toxin Weapons Convention (Chapter 3). This convention tries to ensure that robust domestic arrangements are put into place to translate international commitments into effective national action (Factsheet 2). Strong national efforts and international action cannot, however, take place in a vacuum. They are ultimately driven by, and depend upon the support of, civil society. Prior to the creation of the BWPP, civil society lacked a coherent voice in discussion on how to prevent the malign use of the life sciences. This book is a testimony to the important contribution that civil society can make to international peace and security. There can be little doubt that the life sciences are advancing faster than ever before (Chapter 4) and that this brings with it a raft of new challenges – for civil society, to understand increasingly arcane technological developments; for scientists, to ensure that their work is not misused by others; for policy makers, to design oversight frameworks capable of keeping abreast of such rapid progress; and for industry, to find ways to talk about issues that can be both unfamiliar and uncomfortable. Efforts to prevent other related technologies from being used as weapons have faced similar hurdles in the past. There are important lessons that we can draw from these efforts and it is useful to compare and contrast approaches in the biological field with, say, efforts to prevent the hostile use of chemistry through the Chemical Weapons Convention (Chapter 5). As the former United Nations Secretary General, Kofi Annan, pointed out in April 2006, dealing with the threat posed by biological weapons is unique and requires “innovative solutions specific to the nature of the threat”.1 This will require us to better characterize what that threat actually is. We need to look at the issue of biological weapons through a variety of lenses, including as a public health issue (Chapter 6), an environmental issue (Chapter 7) and as a biodiversity issue (Chapter 8). It is clear that oversight efforts will require the support of all relevant stakeholder communities but will require particular buy-in from the scientists and technologists who pursue biology on a day to basis. This makes mechanisms for raising awareness and inculcating a culture of responsibility (Chapter 9) ever more important. It is hoped that this book will be a useful tool for future efforts. This book was funded and created through the unwavering support of the Swedish government. BWPP’s thanks must go out to Magnus Hellgren of the Geneva Disarmament Mission for his personal championing of this project. This book would not be here without him. Equally, the personal thanks of the editors go out to the chapter authors, who showed remarkable flexibility in putting together such impressive texts under trying circumstances. Finally, our personal thanks also go out to Piers Millett who helped put the final text together into its final format. Although every effort has been taken to remove errors and inconsistencies from this text, undoubtedly some will have slipped through – they must remain the sole responsibility of the editors. Kathryn McLaughlin, for the editors April 2009 1 K. Annan, Uniting Against Terrorism: Recommendations for a Global Counter-Terrorism Strategy (New York: United Nations) April 2006. Available at: http://www.un.org/unitingagainstterrorism - ii - Abbreviations ABWs Advanced Biological Warfare Agents ASM American Society for Microbiology BSE Bovine Spongiform Encephalopathy BW Biological Weapons BWC or BTWC Biological and Toxin Weapons Convention CBMs Confidence-Building Measures CCD Conference of the Committee on Disarmament CDC Centers for Disease Control and Prevention CNAs Compendiums of National Activities CW Chemical Weapons CWC Chemical Weapons Convention DNA Deoxyribonucleic Acid DSTO Defence Science and Technology Organisation DOC Discrete Organic Chemical ENDC Eighteen Nation Disarmament Committee FBI Federal Bureau of Investigation FMD Foot and Mouth Disease FBCA Fungal Biocontrol Agents GOARN Global Outbreak Alert and Response Network GP Geneva Protocol iGEM International Genetically Engineered Machine Competition ICRC International Committee of the Red Cross IL Interleukin ISU Implementation Support Unit to the Biological and Toxin Weapons Convention - iii - NBC Nuclear, biological and chemical NID National Implementation Database NIM National Implementing Measures NIM Project VERTIC’s National Implementing Measures Project OPCW Organisation for the Prohibition of Chemical Weapons RHD Rabbit haemorrhagic disease RNA Ribonucleic acid RRL Roodeplaat Research Laboratories SARS Severe Acute Respiratory Syndrome TNFα Tumour necrosis factor alpha UN United Nations UNSCOM United Nations Special Commission USAMRIID US Army Medical Research Institute for Infectious Diseases VEREX Ad Hoc Group of Governmental Experts to identify and examine potential verification measures from a scientific and technical standpoint VERTIC Verification Research, Training and Information Centre VHF Viral haemorrhagic fever VVND Velogenic Viscerotropic Newcastle Disease WHO World Health Organization WHA World Health Assembly WMD Weapons of mass destruction *** - iv - Chapter 1. An Introduction to Biological Weapons1 Malcolm R. Dando and Kathryn Nixdorff Long before it was understood that microorganisms are the causative agents of infections, contagious disease was exploited as a means of biological warfare. A Brief History of Biological Warfare2 There have been many stories told about the use of biological warfare in antiquity and the Middle Ages. The best
Recommended publications
  • Patentability of Human-Animal Chimeras Ryan Hagglund
    Santa Clara High Technology Law Journal Volume 25 | Issue 1 Article 4 2008 Patentability of Human-Animal Chimeras Ryan Hagglund Follow this and additional works at: http://digitalcommons.law.scu.edu/chtlj Part of the Law Commons Recommended Citation Ryan Hagglund, Patentability of Human-Animal Chimeras, 25 Santa Clara High Tech. L.J. 51 (2012). Available at: http://digitalcommons.law.scu.edu/chtlj/vol25/iss1/4 This Article is brought to you for free and open access by the Journals at Santa Clara Law Digital Commons. It has been accepted for inclusion in Santa Clara High Technology Law Journal by an authorized administrator of Santa Clara Law Digital Commons. For more information, please contact [email protected]. PATENTABILITY OF HUMAN-ANIMAL CHIMERAS Ryan Hagglundt Abstract The chimera was a mythological creature with a lion 's head, goat's body, and serpent's tail. Because of recent advances in biotechnology, such permutations on species are no longer the stuff of myth and legend The term "chimera " has come to describe a class of genetically engineered creatures composed of some cells from one species, which thus contain genetic material derived entirely from that species, and some cells from another species, containing only genetic material from that species. Scientists have created a goat- sheep chimera or "geep" which exhibits physical characteristicsof both animals. Likewise, scientists have also used the tools of modern molecular biology to create human-animal chimeras containing both human and animal cells. While none of the human-animal chimeras hitherto created have exhibited significant human characteristics,the synthesis of human-animal chimeras raises significant ethical concerns.
    [Show full text]
  • The National Biodefense Analysis and Countermeasures Center: Issues
    = -*=&9.43&1= .4)*+*38*=3&1>8.8=&3)= 4:39*72*&8:7*8=*39*7a=88:*8=+47=43,7*88= &3&=_=-*&= 5*(.&1.89=.3=(.*3(*=&3)=*(-3414,>=41.(>= :1>=+3`=,**1= 43,7*88.43&1= *8*&7(-=*7;.(*= 18/1**= <<<_(78_,4;= -,23+= =*5479=+47=43,7*88 Prepared for Members and Committees of Congress -*=&9.43&1= .4)*+*38*=3&1>8.8=&3)=4:39*72*&8:7*8=*39*7a=88:*8=+47=43,7*88= = :22&7>= The mission of the National Biodefense Analysis and Countermeasures Center (NBACC) is to understand current and future biological threats; assess vulnerabilities and determine potential consequences; and provide a national capability for conducting forensic analysis of evidence from bio-crimes and bio-terrorism. The NBACC is operational, with a program office and several component centers occupying interim facilities. A laboratory facility dedicated to executing the NBACC mission and to contain two NBACC component centers is being built at Fort Detrick, Maryland, as part of the National Interagency Biodefense Campus. The laboratory facility, with an estimated construction cost of $141 million, will be the first Department of Homeland Security laboratory specifically focused on biodefense. Its programmatic contents and component organization appear to be evolving, as conflicting information has been provided during previous budget cycles. Congressional oversight of programs, especially those performed in federal facilities for homeland security purposes, is considered key to maintaining transparency in biodefense. Policy issues that may interest Congress include the operation of the NBACC facility as a federally funded research and development center, transparency and oversight of research activities performed through the center, and the potential for duplication and coordination of research effort between the Department of Homeland Security and other federal agencies.
    [Show full text]
  • Maximum Containment: the Most Controversial Labs in the World
    Maximum Containment: The Most Controversial Labs in the World By Alison K. Bruzek B.A. Biological Sciences Northwestern University, 2010 SUBMITTED TO THE PROGRAM IN COMPARATIVE MEDIA STUDIES/WRITING IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN SCIENCE WRITING AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY MASSACHUSETTS IN'T-QUTE OF 7ECHNOLOqi September 2013 JUL 0 22013 @2013 Alison K. Bruzek. All rights reserved. Li__RARI ES The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature of Author: -----.. Program in Con rativeMedia Studies/Writing June 10, 2013 Certified by: Philip Hilts Director, Knight Science Journalism Fellowships Thesis Supervisor Accepted by: Seth Mnookin Assistant Professor of Science Writing Director, Graduate Program in Science Writing 1 2 Maximum Containment: The Most Controversial Labs in the World By Alison K. Bruzek Submitted to the Program in Comparative Media Studies/Writing on June 10, 2013 in Partial Fulfillment of the Requirements for the Degree of Master of Science in Science Writing ABSTRACT In 2002, following the September 1 1 th attacks and the anthrax letters, the United States allocated money to build two maximum containment biology labs. Called Biosafety Level 4 (BSL-4) facilities, these labs were built to research new vaccines, diagnostics, and treatments for emerging infectious diseases, potential biological weapons, and to contribute to the nation's biodefense. These labs were not the first dramatic reaction to the threat of biowarfare and are in fact, one product of a long history of the country's contentious relationship with biological weapons.
    [Show full text]
  • Responsible Life Sciences Research for Global Health Security a Guidance Document WHO/HSE/GAR/BDP/2010.2
    Responsible life sciences research for global health security A GUIDANCE DOCUMENT WHO/HSE/GAR/BDP/2010.2 Responsible life sciences research for global health security A GUIDANCE DOCUMENT © World Health Organization 2010 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be ad- dressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publica- tion. However, the published material is being distributed without warranty of any kind, either expressed or implied.
    [Show full text]
  • High-Risk Human-Caused Pathogen Exposure Events from 1975-2016
    F1000Research 2021, 10:752 Last updated: 04 AUG 2021 DATA NOTE High-risk human-caused pathogen exposure events from 1975-2016 [version 1; peer review: awaiting peer review] David Manheim 1, Gregory Lewis2 11DaySooner, Delaware, USA 2Future of Humanity Institute, University of Oxford, Oxford, UK v1 First published: 04 Aug 2021, 10:752 Open Peer Review https://doi.org/10.12688/f1000research.55114.1 Latest published: 04 Aug 2021, 10:752 https://doi.org/10.12688/f1000research.55114.1 Reviewer Status AWAITING PEER REVIEW Any reports and responses or comments on the Abstract article can be found at the end of the article. Biological agents and infectious pathogens have the potential to cause very significant harm, as the natural occurrence of disease and pandemics makes clear. As a way to better understand the risk of Global Catastrophic Biological Risks due to human activities, rather than natural sources, this paper reports on a dataset of 71 incidents involving either accidental or purposeful exposure to, or infection by, a highly infectious pathogenic agent. There has been significant effort put into both reducing the risk of purposeful spread of biological weapons, and biosafety intended to prevent the exposure to, or release of, dangerous pathogens in the course of research. Despite these efforts, there are incidents of various types that could potentially be controlled or eliminated by different lab and/or bioweapon research choices and safety procedures. The dataset of events presented here was compiled during a project conducted in 2019 to better understand biological risks from anthropic sources. The events which are listed are unrelated to clinical treatment of naturally occurring outbreaks, and are instead entirely the result of human decisions and mistakes.
    [Show full text]
  • Molecular Phylogenetic Analysis
    Assignment #2 Physics 498: Statistical Physics of Biological Complexity and Information Molecular Phylogenetic Analysis Date of Submission: 31th October, 2001 Rahul Roy Center for Biophysics and Computational Biology University of Illinois at Urbana-Champaign email: [email protected] Evolve by Borrowing ? Rahul Roy Center for Biophysics and Computational Biology University of Illinois at Urbana Champaign Introduction Molecular evolution over a period of four billion years has resulted in the development of present myriad of species from a hot soup of molecules. It has resulted in the evolution of complex multicellular organisms (Eukaryotes) along with single-celled organisms like prokaryotes at the same time. The question that has baffled scientists for long is: how did this incredible transition from a soup to this complex state take place? The discussion, that still continues, as how life started from the primordial soup is not the emphasis of the present debate, though Stanley Miller showed in, as back as 1950s, that organic chemicals can be synthesized from completely inorganic inputs. It has been proposed based on structural and functional complexity and fossil evidence that prokaryotes must have predated the eukaryotes by at least 1.0-2.0 billion years [Knoll, 1992]. This has led to the notion that eukaryotic cells have evolved from more simple prokaryotic organisms with which they share numerous common (or related) molecules [Margulis, 1970; Zillig, 1991]. Indeed, studies have shown that a number of eukaryotic organelles (namely mitochondria and chloroplasts) bear a close evolutionary relationship to specific groups of prokaryotes (namely α-proteobacteria and cyanobacteria, respectively) [Gray, 1992] So, how did the complex multicellular eukaryotes evolve from prokaryotes? To understand the origin of the eukaryotic cells a number of theories have been proposed.
    [Show full text]
  • Studies of Military R&D and Weapons Development: Offensive/Defense
    5. The Question of Offensive/Defensive Distinctions in Biological Weapons Related Research, and the Potential Stimulus to BW Proliferation by Expanded Research Programs The word "research," or any specific reference to "offensive" or "defensive" in a research context, does not appear in Article I of the Biological Weapons Convention. That reads as follows: "Each State Party to the Convention undertakes never in any circumstances to develop, produce, stockpile or otherwise acquire or retain: (1) Microbial or other biological agents, or toxins whatever their origin or method of production, of types and in quantities that have no justification for prophylactic, protective or other peaceful purposes; (2) Weapons, equipment or means of delivery designed to use such agents or toxins for hostile purposes or in armed conflict.,,1 However, the word research did appear in the provisional treaty draft that had been drawn up by the U.K. and that had been presented to the negotiating states on July 10, 1969. That draft required states signing or ratifying the treaty "not to conduct, assist or permit research aimed at production ... " of the agents or weapons forbidden by Article I (1) and (2) above. 2 Even earlier in a working paper on microbiological warfare that the U.K. submitted to the states negotiating in Geneva, the U.K. stated: The Convention would also need to deal with research work. It should impose a ban on research work aimed at production of the kind prohibited above, as regards both microbiological agents and ancillary equipment. It should also provide for the appropriate civil medical or health authorities to have access to all research work which might give rise to allegations that the obligations imposed by the Convention were not being fulfilled.
    [Show full text]
  • The Sunshine Project
    the sunshine project Key: High Containment Labs and Other Facilities of the US Biodefense Program This map shows existing biosafety level three and four facilities used in US biodefense research, as well as planned biodefense labs. It also shows important aerosol facilities and open air testing locations used in biodefense. BSL-3/4 facilities not known to be heavily dedicated to biodefense are not indicated here. Operational BSL-4 Facilities (Major) Planned / Under Construction BSL-3 Facilities USAMRIID Fort Detrick, Frederick, Maryland Tufts University, Grafton, Massachusetts DCLS "Biotech Six", Richmond, Virginia UMD of New Jersey, Newark Centers for Disease Control, Atlanta, Georgia (x2) University of Pittsburgh, Pennsylvania Univ. of Texas Medical Branch, Galveston University of Maryland, Baltimore Southwest Fdtn for Biomed. Res., San Antonio, TX George Mason University, Fairfax, Virginia University of Lousiville, Kentucky Planned / Under Construction BSL-4 Facilities Duke University, Durham, North Carolina Boston University, Boston, Massachusetts Medical University Of South Carolina, Charleston NIH Integrated Res. Fac., Frederick, Maryland University of Georgia, Athens DHS NBACC (Phase 1), Frederick, Maryland Scripps Institute, Palm Beach County, Florida USAMRIID (Phase 1), Frederick, Maryland University of Alabama at Birmingham USDA Planned Facility, Frederick, Maryland University of Tennessee at Memphis Univ. of Texas Medical Branch, Galveston Tulane Primate Center, Covington, Louisiana Rocky Mountain Labs, Hamilton, Montana University of Missouri, Columbia Operational BSL-3 Facilities University of Iowa, Iowa City (RCE planning) Harvard University, Cambridge, MA USDA / Iowa State University, Ames, IA Cornell University, Ithaca, New York Argonne National Lab, Argonne, Illinois DHS / USDA Plum Island, New York Agricultural Biosecurity Ctr., Manhattan, Kansas CALSPAN-UB, Buffalo, New York Univ.
    [Show full text]
  • Biosecurity: a Comprehensive Action Plan Center for American Progress
    Center for American Progress Biosecurity A Comprehensive Action Plan Andrew J. Grotto Jonathan B. Tucker Progressive Ideas for a Strong, Just, and Free America Biosecurity: A Comprehensive Action Plan Center for American Progress Biosecurity A Comprehensive Action Plan Andrew J. Grotto and Jonathan B. Tucker June 2006 After Guantanamo: A Special Tribunal for International Terrorist Suspects 1 Biosecurity: A Comprehensive Action Plan Center for American Progress Table of Contents EXECUTIVE SUMMARY i BIOLOGICAL THREATS FACING THE UNITED STATES 1 PREVENTING BIO-CATASTROPHES: THE NEED FOR A GLOBAL APPROACH 9 PREVENTING THE MISUSE OF THE LIFE SCIENCES 9 RECOMMENDATIONS STRENGTHENING BIOLOGICAL DISARMAMENT MEASURES 14 RECOMMENDATIONS 8 CONTAINING DISEASE OUTBREAKS: AN INTEGRATED PUBLIC HEALTH STRATEGY 21 TIMELY DETECTION OF OUTBREAKS 22 RECOMMENDATIONS 0 RAPID CONTAINMENT OF OUTBREAKS 32 RECOMMENDATIONS 5 DEFENDING AGAINST BIOLOGICAL THREATS: AN INTEGRATED RESEARCH STRATEGY 37 REFORMING THE DRUG DEVELOPMENT PROCESS 38 RECOMMENDATIONS 41 RATIONALIZING BIODEFENSE SPENDING 42 RECOMMENDATIONS 44 GLOSSARY 47 Biosecurity: A Comprehensive Action Plan ACKNOWLEDGMENTS The authors are deeply grateful to the following individuals for their valuable comments and criticisms on earlier drafts of this report: Bob Boorstin, Joseph Cirincione, P. J. Crowley, Richard Ebright, Gerald L. Epstein, Trevor Findlay, Brian Finlay, Elisa D. Harris, David Heyman, Ajey Lele, Dan Matro, Caitriona McLeish, Jonathan Moreno, Peter Ogden, Alan Pearson, Michael Schiffer, Laura Segal, and Bradley Smith. 4 Center for American Progress Executive Summary iological weapons and infectious diseases share several fundamental characteristics that the United States can leverage to counter both Bof these threats more effectively. Both a bioweapons attack and a natural pandemic, such as avian flu, can be detected in similar ways, and the effectiveness of any response to an outbreak of infectious disease, whether natural or caused deliberately by terrorists, hinges on the strength of the U.S.
    [Show full text]
  • Pacific Forum Csis Young Leaders
    The Biosecurity Lexicon Project: Breaking down the Complexities of Biosecurity Science for Policymakers PACIFIC FORUM CSIS YOUNG LEADERS Issues & Insights Vol. 12 – No. 11 Hanoi, Vietnam November 2012 Pacific Forum CSIS Based in Honolulu, the Pacific Forum CSIS (www.pacforum.org) operates as the autonomous Asia-Pacific arm of the Center for Strategic and International Studies in Washington, DC. The Forum’s programs encompass current and emerging political, security, economic, business, and oceans policy issues through analysis and dialogue undertaken with the region’s leaders in the academic, government, and corporate arenas. Founded in 1975, it collaborates with a broad network of research institutes from around the Pacific Rim, drawing on Asian perspectives and disseminating project findings and recommendations to opinion leaders, governments, and members of the public throughout the region. The Young Leaders Program The Young Leaders Program invites young professionals and scholars to join Pacific Forum policy dialogues and conferences. The program fosters education in the practical aspects of policy-making, generates an exchange of views between young and seasoned professionals, builds adaptive leadership capacity, promotes interaction among younger professionals from different cultures, and enriches dialogues with generational perspectives for all attendees. Participants must have a strong background in the area covered by the conference they are attending and an endorsement from respected experts in their field. Supplemental programs in conference host cities and mentoring sessions with senior officials and experts add to the Young Leader experience. The Young Leaders Program is possible with generous funding support by governments and philanthropic foundations, together with a growing number of universities, institutes, and organizations also helping to sponsor individual participants.
    [Show full text]
  • Formation and Longevity of Chimeric and Duplicate Genes in Drosophila Melanogaster
    Copyright Ó 2009 by the Genetics Society of America DOI: 10.1534/genetics.108.091538 Formation and Longevity of Chimeric and Duplicate Genes in Drosophila melanogaster Rebekah L. Rogers,1 Trevor Bedford2 and Daniel L. Hartl Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, Massachusetts 02138 Manuscript received May 15, 2008 Accepted for publication November 11, 2008 ABSTRACT Historically, duplicate genes have been regarded as a major source of novel genetic material. However, recent work suggests that chimeric genes formed through the fusion of pieces of different genes may also contribute to the evolution of novel functions. To compare the contribution of chimeric and duplicate genes to genome evolution, we measured their prevalence and persistence within Drosophila melanogaster. We find that 80.4 duplicates form per million years, but most are rapidly eliminated from the genome, leaving only 4.1% to be preserved by natural selection. Chimeras form at a comparatively modest rate of 11.4 per million years but follow a similar pattern of decay, with ultimately only 1.4% of chimeras preserved. We propose two mechanisms of chimeric gene formation, which rely entirely on local, DNA-based mutations to explain the structure and placement of the youngest chimeric genes observed. One involves imprecise excision of an unpaired duplication during large-loop mismatch repair, while the other invokes a process akin to replication slippage to form a chimeric gene in a single event. Our results paint a dynamic picture of both chimeras and duplicate genes within the genome and suggest that chimeric genes contribute substantially to genomic novelty.
    [Show full text]
  • Infectious Enveloped RNA Virus Antigenic Chimeras (Alphaviruses/Random Mutagenesis/Virus Vectors/Protein Engineering/Glycoproteins) STEVEN D
    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 207-211, January 1992 Biochemistry Infectious enveloped RNA virus antigenic chimeras (alphaviruses/random mutagenesis/virus vectors/protein engineering/glycoproteins) STEVEN D. LONDON*, ALAN L. SCHMAUOHNt, JOEL M. DALRYMPLEt, AND CHARLES M. RICE*t *Department of Molecular Microbiology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8230, St. Louis, MO 63110-1093; and tUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011 Communicated by Edwin D. Kilbourne, October 7, 1991 (receivedfor review August 26, 1991) ABSTRACT Random insertion mutagenesis has been used would allow recovery of infectious chimeric viruses. The to construct infectious Sindbis virus structural protein chime- insertional mutagen was an oligonucleotide encoding an ras containing a neutralization epitope from a heterologous 11-amino acid neutralization epitope (4D4) derived from the virus, Rift Valley fever virus. Insertion sites, permissive for external G2 glycoprotein of Rift Valley fever virus (RVFV). recovery of chimeric viruses with growth properties similar to Both a polyclonal anti-peptide antiserum and a monoclonal the parental virus, were found in the virion E2 glycoprotein and antibody (mAb), mAb 4D4, that react with this epitope on the secreted E3 glycoprotein. For the E2 chimeras, the epitope RVFV virions and also with denatured and reduced RVFV was expressed on the virion surface and stimulated a partially G2 (13, 14) are available. Thus,
    [Show full text]